-
2025-524366-21-00
5
2026-04-29
treatment-naive Chronic Lymphocytic Leukemia
-
2024-511593-70-00
5
2026-04-27
Polyarticular-course juvenile idiopathic arthritis
-
2024-519830-22-00
5
2026-04-27
Heart failure due to systemic left ventricular systolic dysfunction
-
2025-521936-12-00
5
2026-04-24
Adults with Type 2 Diabetes and/or Metabolic Syndrome on guideline re
-
2024-519699-24-00
4
2026-04-23
IgA nephropathy
-
2024-517943-29-00
5
2026-04-21
Pulmonary Hypertension associated with interstitial lung disease (WHO
-
2025-522878-36-00
5
2026-04-20
Chronic Spontaneous Urticaria
-
2025-521521-33-00
10
2026-04-02
Kidney transplant rejection
-
2025-521730-28-00
4
2026-03-30
Colorectal Cancer with Cancer Cachexia
-
2025-521142-22-00
5
2026-03-27
Hereditary Angioedema
-
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2025-521884-12-00
5
2026-03-19
First line triple-negative breast cancer (TNBC)
-
2025-523202-32-00
5
2026-02-26
Major Depressive Disorder
-
2024-519068-42-00
10
2026-02-12
Heterozygous Familial Hypercholesterolemia in pediatric patients
-
2025-521558-40-00
5
2026-02-12
Pulmonary Hypertension Associated with Interstitial Lung Disease
-
2025-522170-36-00
5
2026-02-03
Diabetes Mellitus, Type 1
-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2025-521352-38-00
5
2026-01-16
Hereditary Angioedema
-
2025-522052-13-00
10
2025-12-24
Framework for Optimizing, Refining, and Unifying Management of HSCT in
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2025-522070-36-00
5
2025-12-15
immune thrombocytopenia (ITP)
-
2024-517923-38-00
3
2025-12-10
Newly diagnosed and/or previously treated IDH1-mutated malignancies